This is the legacy version of We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
The Sweet Lab 8 Jun 16
Sweet Lab paper indicates efforts to therapeutically target glutamate receptors in AD may depend on APOE*4 genotype.